Menlo Park, CA, United States of America

Robert Kastelein

USPTO Granted Patents = 14 

Average Co-Inventor Count = 3.5

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2024-2025

Loading Chart...
14 patents (USPTO):Explore Patents

Title: The Innovative Genius of Robert Kastelein: Pioneering Advances in Cytokine Research

Introduction: Robert Kastelein, a notable inventor based in Menlo Park, California, has made significant contributions to the field of biotechnology, particularly in the development of biologically active molecules. With a remarkable portfolio of 13 patents, Kastelein is at the forefront of innovation in cytokine research, aiming to address crucial therapeutic needs.

Latest Patents: Among his latest inventions are two groundbreaking patents. The first is focused on IL10RA binding molecules and methods of use, detailing biologically active molecules comprising a single domain antibody (sdAb) that specifically binds to the extracellular domain of human IL10Ra. This innovation includes compositions comprising such antibodies and outlines various methods for their utilization. The second patent involves IL12 receptor synthetic cytokines and methods of use, which provides IL12R binding molecules that effectively bind to IL12Rb1 and IL12Rb2 and consist of an anti-IL12Rb2 sdAb alongside an anti-IL12Rb2 VH antibody. These patents signify advancements in targeted therapies and illustrate Kastelein's commitment to pushing scientific boundaries.

Career Highlights: Robert Kastelein's career is marked by his association with Synthekine, Inc., where he utilizes his expertise to drive forward the development of novel therapies. His prolific nature as an inventor and a researcher has positioned him as a key player in the biotechnology sector.

Collaborations: Throughout his career, Kastelein has collaborated with talented professionals, including Deepti Rokkam and Patrick J Lupardus, who share his vision for innovative therapeutic solutions. These collaborations often lead to the creation of cutting-edge technologies and advances in cancer treatment and autoimmune diseases.

Conclusion: Robert Kastelein's impressive body of work reflects his unwavering dedication to advancing the field of biotechnology. With a focus on cytokine research and innovative methodologies, he continues to influence the landscape of therapeutic development, inspiring future inventors and researchers in the industry. His inventions hold the promise of transforming patient care and addressing significant health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…